List of works - Nora Hagelberg

Acute pain intensity monitoring with the classification of multiple physiological parameters

scientific article published on 26 June 2018

Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects

scientific article published in May 2004

Altered dopamine D2 receptor binding in atypical facial pain

scientific article published in November 2003

Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia

scientific article

COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo

scientific article published in October 2009

Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine

scientific article published on 7 November 2009

Correlation of human cold pressor pain responses with 5-HT1A receptor binding in the brain

article

Differential associations between brain 5-HT(1A) receptor binding and response to pain versus touch.

scientific article

Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity

scientific article published in September 2002

Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brain

scholarly article by Ilkka K. Martikainen et al published July 2018 in European Journal of Pharmacology

Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study

scientific article published on 01 January 2011

Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone

scientific article published on 15 September 2009

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

scientific article published on April 2010

Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol

scientific article published on 06 January 2015

Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone

scientific article

Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study

scientific article published on 01 December 2020

Febrile infant

scientific article published on January 1996

Fentanyl for breakthrough cancer pain--what's new?

scientific article published on December 2010

Grapefruit juice enhances the exposure to oral oxycodone

scientific article

Inhibition of Cytochrome P450 3A by Clarithromycin Uniformly Affects the Pharmacokinetics and Pharmacodynamics of Oxycodone in Young and Elderly Volunteers

scientific article published on 01 June 2011

Interaction of oxycodone and voriconazole—a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects

scientific article published on 11 January 2011

Investigation of drug-drug interactions and pain-From volunteer studies to randomized controlled trials in patients with chronic pain

scientific article published on 01 January 2010

Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy

scientific article published on 30 March 2016

Machine learning suggests sleep as a core factor in chronic pain

scientific article published on 13 July 2020

Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects

scientific article

Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride

scientific article published in December 2003

Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4.

scientific article

Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.

scientific article

Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids

scientific article published on 11 May 2017

Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir

scientific article published on 10 August 2010

Oxycodone: new 'old' drug

scientific article published on August 2009

Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing

scientific article

Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain

scientific article published on 01 October 2011

Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug-drug interactions

scientific article published on 01 January 2012

Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects

scientific article

Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine

scientific article

Rifampicin markedly decreases the exposure to oral and intravenous tramadol

scientific article published on 15 December 2012

Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone

scientific article

Right secondary somatosensory cortex-a promising novel target for the treatment of drug-resistant neuropathic orofacial pain with repetitive transcranial magnetic stimulation

scientific article published in July 2015

S-ketamine concentrations are greatly increased by grapefruit juice

scientific article

Social work in a pain clinic

scientific article published on 01 October 2010

St John's wort greatly decreases the plasma concentrations of oral S-ketamine

scientific article

St John's wort greatly reduces the concentrations of oral oxycodone

scientific article published on 27 January 2010

Striatal dopamine D1 and D2 receptors in burning mouth syndrome

scientific article

Striatal dopamine D2 receptors in modulation of pain in humans: a review

scientific article published in October 2004

Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain

scientific article published in September 2004

Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects

scientific article

The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disorders

scientific article published on November 2016

The association between physicians’ attitudes to psychosocial aspects of low back pain and reported clinical behaviour: A complex issue

The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects

scientific article

Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction

scientific article published on 26 October 2012

Ultra-short-term analysis of heart rate variability for real-time acute pain monitoring with wearable electronics

Update on current care guidelines. Pain

scientific article published on January 2016

Validation of EQ-5D and 15D in the assessment of health-related quality of life in chronic pain

scientific article published in August 2017

Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation

scientific article published on 29 August 2014

Voriconazole drastically increases exposure to oral oxycodone

scientific article published on 3 October 2008

Voriconazole greatly increases the exposure to oral buprenorphine

scientific article published on 30 August 2018

Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction

scientific article published on 10 August 2016

[Can we prevent pain becoming chronic?]

scientific article published on 01 January 2015

List of works by Nora Hagelberg

Acute pain intensity monitoring with the classification of multiple physiological parameters

Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects

Altered dopamine D2 receptor binding in atypical facial pain

Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia

COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo

Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine

Correlation of human cold pressor pain responses with 5-HT1A receptor binding in the brain

Differential associations between brain 5-HT(1A) receptor binding and response to pain versus touch.

Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity

Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brain

Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study

Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol

Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone

Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study

Febrile infant

Fentanyl for breakthrough cancer pain--what's new?

Grapefruit juice enhances the exposure to oral oxycodone

Inhibition of Cytochrome P450 3A by Clarithromycin Uniformly Affects the Pharmacokinetics and Pharmacodynamics of Oxycodone in Young and Elderly Volunteers

Interaction of oxycodone and voriconazole—a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects

Investigation of drug-drug interactions and pain-From volunteer studies to randomized controlled trials in patients with chronic pain

Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy

Machine learning suggests sleep as a core factor in chronic pain

Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects

Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride

Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4.

Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.

Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids

Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir

Oxycodone: new 'old' drug

Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing

Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain

Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug-drug interactions

Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects

Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine

Rifampicin markedly decreases the exposure to oral and intravenous tramadol

Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone

Right secondary somatosensory cortex-a promising novel target for the treatment of drug-resistant neuropathic orofacial pain with repetitive transcranial magnetic stimulation

S-ketamine concentrations are greatly increased by grapefruit juice

Social work in a pain clinic

St John's wort greatly decreases the plasma concentrations of oral S-ketamine

St John's wort greatly reduces the concentrations of oral oxycodone

Striatal dopamine D1 and D2 receptors in burning mouth syndrome

Striatal dopamine D2 receptors in modulation of pain in humans: a review

Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain

Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects

The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disorders

The association between physicians’ attitudes to psychosocial aspects of low back pain and reported clinical behaviour: A complex issue

The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects

Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction

Ultra-short-term analysis of heart rate variability for real-time acute pain monitoring with wearable electronics

Update on current care guidelines. Pain

Validation of EQ-5D and 15D in the assessment of health-related quality of life in chronic pain

Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation

Voriconazole drastically increases exposure to oral oxycodone

Voriconazole greatly increases the exposure to oral buprenorphine

Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction

[Can we prevent pain becoming chronic?]